Immune checkpoint blockade enhances CD4 effector function and enables control of persistent viral infection 2310195
A previously unrecognized and novel, IL-27—independent CD4+ T cell axis through which PD-1 checkpoint blockade restores antiviral immunity during persistent viral infection is revealed, redefining the mechanistic landscape of checkpoint immunotherapy.